Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Saved in:
| Title: | Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children. |
|---|---|
| Authors: | Chen, Ruyue1 (AUTHOR), Lin, Qiang1 (AUTHOR), Zhu, Yun1 (AUTHOR), Shen, Yunyan1 (AUTHOR), Xu, Qinying1 (AUTHOR), Tang, Hanyun1 (AUTHOR), Cui, Ningxun1 (AUTHOR), Jiang, Lu1 (AUTHOR), Dai, Xiaomei1 (AUTHOR), Chen, Weiqing1 (AUTHOR), Li, Xiaozhong1 (AUTHOR) xiaozhonglicn@yeah.net |
| Source: | Orphanet Journal of Rare Diseases. 9/22/2023, Vol. 18 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
